Teva to build new headquarters in Tel Aviv - Globes
Teva Pharmaceuticals | LinkedIn
What To Do After EU Hits Teva With Antitrust Concerns (NYSE:TEVA) | Seeking Alpha
EU regulators charge Teva over pay-for-delay drug deal – New York Daily News
Brussels' Teva probe reveals dark side of patent protections
EU Copaxone antitrust findings hit Teva - Globes
Anything but Generic: A map for Selling to Teva Pharmaceuticals
Teva shares plunge as competitors get nod for copycat flagship drug | The Times of Israel
EU accuses Teva Pharmaceutical of anti-competitive behaviour
We interview Val Petursson, Senior Director of Global Transportation at Teva Pharmaceuticals - Issuu
Teva Pharmaceuticals Europe - With #ERSCongress 2019 approaching, the Let's Talk Respiratory team want to give you a flavour of things to come. From Q&As, symposiums, and a booth we know you'll
Teva Restructuring Coming Together, Rebuilding Confidence in the Company | BioSpace
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Teva's Deal for Mylan Shows Corporate Israel's M&A Hunger - WSJ
Teva Reaches Tentative $4.25 Billion Settlement Over Opioids - The New York Times
Teva Pharma opens $110M plant in Hungary | Fierce Pharma
Teva gets EU nod for severe asthma drug Cinqaero - PMLiVE
InnovationRx: Israel Makes Up 8% Of Teva's Global Production
Teva EU factsheet - Marketing Medicines In Europe
EU antitrust authorities launch probe of Teva over Copaxone drug | The Times of Israel
EU Commission opens antitrust probe into Teva
Teva Pharmaceuticals Sterile Manufacturing Facility, Ulm - Pharmaceutical Technology
TEVA stock on watch after EU approval for biosimilar to Roche's Lucentis (NYSE:TEVA) | Seeking Alpha
Teva's Israeli Plant Receives FDA Stamp of Approval for Migraine Drug Manufacturing | Ctech
Exclusive - Teva set to win EU okay for $40.5 billion Allergan deal: sources | Reuters
Teva Pharmaceuticals to Cut 25% of Jobs in Huge Reshaping - The New York Times
